FDA approves J&J's ketamine-like nasal spray for depression

5:15pm PST - March 5th, 2019    ketamine - Reuters

The U.S. Food and Drug Administration on Tuesday said it approved Johnson & Johnson's nasal spray antidepressant that is chemically similar to often-abused ketamine, marking the first advance in treating depression in more than 30 years.